Icahn School of Medicine at Mount Sinai — New York, New York

Icahn School of Medicine at Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai has participated in 1138 clinical trials with 349 currently active.

Therapeutic areas: Active Systemic Lupus Erythematosus, Prostate Cancer, Atopic Dermatitis.

Sponsors: Amgen, Icahn School of Medicine at Mount Sinai, Pfizer.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai?

Icahn School of Medicine at Mount Sinai has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai conducted?

Icahn School of Medicine at Mount Sinai has 1138 clinical trials on record, with 349 currently active. Their work covers Active Systemic Lupus Erythematosus, Prostate Cancer, Atopic Dermatitis.

Is Icahn School of Medicine at Mount Sinai accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.